# Comparison of HRS-5965 Capsules and Tablets in Healthy Subjects

> **NCT06490991** · PHASE1 · COMPLETED · sponsor: **Chengdu Suncadia Medicine Co., Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Paroxysmal Nocturnal Hemoglobinuria，IgA Nephropathy

## Interventions

- **DRUG:** HRS-5965 tablets；HRS-5965 capsules

## Key facts

- **NCT ID:** NCT06490991
- **Lead sponsor:** Chengdu Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-17
- **Primary completion:** 2024-08-06
- **Final completion:** 2024-09-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06490991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06490991, "Comparison of HRS-5965 Capsules and Tablets in Healthy Subjects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06490991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*